Medicine details

ImageAvlocid MS
NameAvlocid MS
DosageChewable Tablet
Generic NameMagaldrate + Simethicone
Classes Antacid
Gastrointestinal Agent
Diseases Gas
Gastrointestinal Disease
Heart Burn
Indigestion
Sour Stomach
CompanyACI Limited

Drug Package Details

Strength480 mg + 20 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack100
Price per pack301.00
Cost per pack264.88
Package unit10 tabs strip
Price per unit3.01
Cost per unit2.65
Discount0
Coupon
Remarks

Magaldrate + Simethicone

Magaldrate is a hydroxy-magnesium aluminate complex that is rapidly transformed by gastric acid to Mg(OH)2 and Al(OH)3, which are poorly absorbed and give a long-lasting antacid action. Simethicone is an anti-flatulent that adsorbs excess gas produced in the intestine and helps in elimination.

Magaldrate + Simethicone is indicated for symptomatic relief of the following conditions-

  • Gastric acidity
  • Dyspepsia
  • Flatulence
  • Gastric ulcer
  • Magaldrate + Simethicone is available as chewable tablet and suspension.
  • Tablets: 1-4 chewable tablets, 20-60 minutes after meals and before night, or as prescribed by your doctor.
  • Suspension: The usual dose is 10-20 ml/ 2-4 teaspoonful of suspension, 20 to 60 minutes after meals and at bed time, or as directed by the doctor/pharmacist.

Magaldrate + Simethicone is a well tolerated medication. When taken in excessive amounts, the following side effects may appear-

  • diarrhea
  • abdominal pain
  • constipation
  • taste disturbance (metallic taste, chalky taste)
  • Large doses of this product may trigger or aggravate intestinal obstruction and ileus in patients at higher risk, such as those with renal impairment or the elderly. Aluminium hydroxide may cause constipation, and magnesium salts overdose may cause hypomotility of the bowel; large doses of this product may trigger or aggravate intestinal obstruction and ileus in patients at higher risk, such as those with renal impairment or the elderly.
  • Because aluminum hydroxide is poorly absorbed from the gastrointestinal tract, systemic effects in persons with normal renal function are uncommon. Excessive doses, long-term use, or even typical doses in individuals on low-phosphorus diets can cause phosphate depletion (due to aluminium-phosphate binding), accelerated bone resorption, hypercalciuria, and osteomalacia. Long-term use or people who are at danger of phosphate deficiency should seek medical guidance.
  • Aluminium and magnesium levels in the blood rise in people with renal impairment. Long-term exposure to large dosages of aluminum and magnesium salts may cause dementia and microcytic anemia in these patients. Patients with porphyria who are receiving hemodialysis may be at risk from aluminum hydroxide.

Contraindication

There's no known contraindications of the medication in terms of food and drinks.

Contraindicated in patients with hypophosphatemia.